To examine the potential of pre-treatment dual time point [F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a tool for improving the assessment of head and neck cancer. Two main areas were investigated: (a) optimum time to start FDG scanning post-injection and (b) potential of SUV obtained from dual time point scanning as a prognostic indicator of survival.
- Dual time imaging
- Head and neck cancer
- Positron emission tomography
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging